1-[(3-chloro-2-fluorophenyl)methyl]-4-[3-(methoxymethyl)-1,2,4-oxadiazol-5-yl]pyrrolidine-3-carboxamide
C16H18ClFN4O3 — CID 156611313
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[(3-chloro-2-fluorophenyl)methyl]-4-[3-(methoxymethyl)-1,2,4-oxadiazol-5-yl]pyrrolidine-3-carboxamide
1-[(3-chloro-2-fluorophenyl)methyl]-4-[3-(methoxymethyl)-1,2,4-oxadiazol-5-yl]pyrrolidine-3-carboxamide (PubChem CID 156611313) has the molecular formula C16H18ClFN4O3 and a molecular weight of 368.80 g/mol. Its IUPAC name is 1-[(3-chloro-2-fluorophenyl)methyl]-4-[3-(methoxymethyl)-1,2,4-oxadiazol-5-yl]pyrrolidine-3-carboxamide.
Molecular Properties
| Compound Name | 1-[(3-chloro-2-fluorophenyl)methyl]-4-[3-(methoxymethyl)-1,2,4-oxadiazol-5-yl]pyrrolidine-3-carboxamide |
|---|---|
| PubChem CID | 156611313 |
| Molecular Formula | C16H18ClFN4O3 |
| Molecular Weight | 368.80 g/mol |
| Exact Mass | 368.11 |
| IUPAC Name | 1-[(3-chloro-2-fluorophenyl)methyl]-4-[3-(methoxymethyl)-1,2,4-oxadiazol-5-yl]pyrrolidine-3-carboxamide |
| SMILES | COCc1noc(C2CN(Cc3cccc(Cl)c3F)CC2C(N)=O)n1 |
| InChI | InChI=1S/C16H18ClFN4O3/c1-24-8-13-20-16(25-21-13)11-7-22(6-10(11)15(19)23)5-9-3-2-4-12(17)14(9)18/h2-4,10-11H,5-8H2,1H3,(H2,19,23) |
| InChIKey | BBHRVJBEYQSLPQ-UHFFFAOYSA-N |
| XLogP | 1.71 |
| TPSA | 94.48 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 25 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 368.80 |
| LogP ≤ 5 | 1.71 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 156611313 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.